Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

PW Medtech Completes $180 Million Hong Kong IPO

publication date: Nov 11, 2013
PW Medtech Group Limited, a Beijing-based medical device company, completed a US$180 million IPO last week on the Hong Kong Exchange. The firm offered 400 million shares at a price of HK$3.18, raising HK$1.27 billion. PW Medtech offers orthopedic implants and infusion equipment. The company said it would allocate 30% of the proceeds to expand, a plan that includes making acquisitions and forming strategic alliances. More details....

Stock Symbol: (HK: 1358)

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital